Perioperative Mindfulness Proposal
Launched by HOAG MEMORIAL HOSPITAL PRESBYTERIAN · Aug 6, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Perioperative Mindfulness Proposal is a clinical trial designed to see if practicing meditation and breathing exercises before and after surgery can help women with breast cancer feel less anxious and experience less pain during their treatment. This study is open to women aged 18 and older who have been newly diagnosed with primary breast cancer and will be undergoing certain types of surgery, like a lumpectomy or mastectomy. However, if someone has a history of major mental health issues or has been practicing meditation regularly in the past year, they won’t be eligible to participate.
Participants in the trial will be asked to engage in mindfulness activities, which can be done through guided sessions accessed on a mobile phone or email. They will also be monitored throughout their surgery and recovery process. This trial is currently recruiting, so if you or a loved one fits the criteria, it might be a helpful opportunity to explore how mindfulness can improve the experience during treatment for breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females 18 years of age or older
- • Subject must be able to speak and read English
- • Newly diagnosed with primary breast cancer
- • Will receive primary surgical treatment for their breast cancer diagnosis.
- • Undergoing lumpectomy with or without autologous reconstruction with or without contralateral surgery for symmetry with or without IORT or simple mastectomy without reconstruction
- • Breast cancer or DCIS
- Exclusion Criteria:
- • Recurrent breast cancer
- • Current or history of major psychiatric diagnosis.
- • Subjects who are receiving neo-adjuvant chemotherapy
- • Subjects undergoing modified radical mastectomy or reconstruction
- • Subjects regular meditation practice within the past 12 months (defined as greater than twice weekly practice)
- • Subjects unwilling or unable to complete study materials or comply with study visits
- • Subjects with no access to email or a mobile phone (required to access meditations)
- • Subjects undergoing surgery outside Hoag
- • Subjects who have narcotic dependence as defined by regular weekly narcotic use before cancer diagnosis.
- • Re-excision after lumpectomy (subjects who require re-excision after initial enrollment will be excluded from final analysis and dropped from the study).
About Hoag Memorial Hospital Presbyterian
Hoag Memorial Hospital Presbyterian is a leading healthcare institution located in Southern California, dedicated to providing high-quality patient care and advancing medical research. As a prominent sponsor of clinical trials, Hoag is committed to exploring innovative therapies and treatments that enhance patient outcomes and contribute to the broader medical community. With a focus on collaboration and ethical research practices, Hoag leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate rigorous clinical investigations across various therapeutic areas, ensuring the highest standards of safety and efficacy in all trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newport Beach, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials